ABSTRACT SUMMARY. A novel oral multiple-unit drug delivery system(DDS), containing a high dose of 5-aminosalicylic acid (5-ASA, mesalamine) was developed. A prolonged release of 5-ASA was achieved, aiming to meet inflammatory bowel disease (IBD) therapeutic needs.
A multiple-unit ileocolonic delivery system containing a high load of 5-ASA / G. Di Pretoro, L. Zema, L. Palugan, D.I. Wilson, S.L. Rough, A. Gazzaniga - In: Proceedings of 2011 CRS Annual Meeting and Exposition[s.l] : CRS (Controlled Release Society), 2011 Jul. (( Intervento presentato al 38. convegno Annual meeting and exposition of the Controlled Release Society (CRS) tenutosi a National Arbor, Maryland nel 2011.
A multiple-unit ileocolonic delivery system containing a high load of 5-ASA
G. Di PretoroPrimo
;L. ZemaSecondo
;L. Palugan;A. GazzanigaUltimo
2011
Abstract
ABSTRACT SUMMARY. A novel oral multiple-unit drug delivery system(DDS), containing a high dose of 5-aminosalicylic acid (5-ASA, mesalamine) was developed. A prolonged release of 5-ASA was achieved, aiming to meet inflammatory bowel disease (IBD) therapeutic needs.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
